CTIX

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 12/28/2016
Contact Info
  • 100 Cummings Center
  • Suite 151-B
  • Beverly, MA 01915

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001355250
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2005
Employees 14 a/o Jul 01, 2016
Company Officers/Contacts
Leo Ehrlich CEO, CFO
Krishna Menon President
Company Directors
Krishna Menon Chairman
Leo Ehrlich
Barry Schechter Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Zorik Spektor Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Mark R. Tobin Independent Director, Audit Committee Member, Compensation Committee Member
Service Providers
Accounting/Auditing Firm
Baker Tilly Virchow Krause
One Penn Plaza
Suite 3000
New York, NY, 10119
United States
 
Securities Counsel
Hogan Lovells US LLP
875 Third Avenue
New York, NY, 10022
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=EconoShare, Inc. until 2-2008
CTIX Security Details
Share Structure
Market Value1 $124,919,182 a/o Mar 23, 2017
Authorized Shares 300,000,000 a/o Mar 17, 2017
Outstanding Shares 127,598,756 a/o Mar 17, 2017
-Restricted 37,167,114 a/o Mar 17, 2017
-Unrestricted 90,431,642 a/o Mar 17, 2017
Held at DTC 89,304,120 a/o Mar 17, 2017
Float 87,137,254 a/o Sep 16, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
West Coast Stock Transfer Inc.
Shareholders
Shareholders of Record 67 a/o Sep 13, 2016
Short Selling Data
Short Interest 871,870 (-0.34%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security